Control of norepinephrine synthesis in blood vessels and the effects of monoamine oxidase inhibition.
D000311:Adrenal Glands / Q000032:analysis / Q000187:drug effects / Q000201:enzymology; D000818:Animals; D001808:Blood Vessels / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism*; D002250:Carbon Radioisotopes; D005246:Feedback; D005470:Fluorometry; D006168:Guinea Pigs; D006321:Heart / Q000032:analysis / Q000187:drug effects; D008297:Male; D008638:Mesenteric Arteries / Q000032:analysis / Q000187:drug effects / Q000201:enzymology; D008642:Mesenteric Veins / Q000032:analysis / Q000187:drug effects / Q000201:enzymology; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology*; D009206:Myocardium / Q000378:metabolism; D009638:Norepinephrine / Q000096:biosynthesis* / Q000302:isolation & purification; D010084:Oxidation-Reduction; D010293:Pargyline / Q000494:pharmacology; D013997:Time Factors; D014316:Tritium; D014443:Tyrosine / Q000378:metabolism; D014446:Tyrosine 3-Monooxygenase / Q000378:metabolism
D002250:Carbon Radioisotopes; D008996:Monoamine Oxidase Inhibitors; D014316:Tritium; D014443:Tyrosine; D010293:Pargyline; D014446:Tyrosine 3-Monooxygenase; D009638:Norepinephrine